1. Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis
   Shi Tang et al, 2017, Mediators of Inflammation CrossRef
2. Long read reference genome-free reconstruction of a full-length transcriptome from Astragalus membranaceus reveals transcript variants involved in bioactive compound biosynthesis
   Jun Li et al, 2017, Cell Discov. CrossRef
3. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy
   Li-Jun Duan et al, 2017, Biochemical and Biophysical Research Communications CrossRef
4. Impact of high glucose and AGEs on cultured kidney-derived cells. Effects on cell viability, lysosomal enzymes and effectors of cell signaling pathways
   Giovani B. Peres et al, 2017, Biochimie CrossRef
5. Long non-coding RNAs: An essential emerging field in kidney pathogenesis.
   Hakimeh Moghaddas Sani et al, 2018, Biomed Pharmacother CrossRef
6. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway
   Huicong Li et al, 2018, European Journal of Pharmacology CrossRef
7. An integrated strategy for extraction and pre-concentration of four astragalosides from Radix Astragali by a formulated surfactant aqueous system
   Suixin Wang et al, 2018, Journal of Industrial and Engineering Chemistry CrossRef
8. Long noncoding RNA NEAT1 accelerates the proliferation and fibrosis in diabetic nephropathy through activating Akt/mTOR signaling pathway
   Shan Huang et al, 2018, J Cell Physiol CrossRef
9. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial‐to‐mesenchymal transition by targeting miR‐27b‐3p and ZEB1 in diabetic nephropathy
   Xiaowei Wang et al, 2018, J Cell Physiol CrossRef
10. Roles of Identified Long Noncoding RNA in Diabetic Nephropathy
    Yan Li et al, 2019, Journal of Diabetes Research CrossRef
11. Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy
    Zubair Ilyas et al, 2017, Rev Endocr Metab Disord CrossRef
12. Shenqi Jiangtang Granule Ameliorates Kidney Function by Inhibiting Apoptosis in a Diabetic Rat Model
    Qian Zhang et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
13. Effect of astragalosides on long non-coding RNA expression profiles in rats with adjuvant-induced arthritis
    Hui Jiang et al, 2019, Int J Mol Med CrossRef
14. Astragaloside IV ameliorates high glucose‑induced renal tubular epithelial‑mesenchymal transition by blocking mTORC1/p70S6K signaling in HK‑2 cells.
    Xiao Chen et al, 0 CrossRef
15. Transcriptomics analysis of sirolimus treatment in lupus nephritis
    Dongdong Wang et al, 2019, Mol Med Report CrossRef
16. Qishen Yiqi Dripping Pill Protects Against Diabetic Nephropathy by Inhibiting the Wnt/β-Catenin and Transforming Growth Factor-β/Smad Signaling Pathways in Rats
    Qian Zhang et al, 2021, Front. Physiol. CrossRef
17. Treatment with astragaloside IV reduced blood glucose, regulated blood lipids, and protected liver function in diabetic rats
    Dong Han, 2021, J Int Med Res CrossRef
18. Carbohydrate response element binding protein (ChREBP) modulates the inflammatory response of mesangial cells in response to glucose
    Yan Chen et al, 2018 CrossRef
19. Qishen Yiqi Dripping Pill Protects Diabetic Nephropathy by Inhibiting the PI3K-AKT Signaling Pathways in Rats
    Shaohua Li et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
20. Clean-DM1, a Korean Polyherbal Formula, Improves High Fat Diet-Induced Diabetic Symptoms in Mice by Regulating IRS/PI3K/AKT and AMPK Expressions in Pancreas and Liver Tissues
    Piao Wang et al, 2023, Chin. J. Integr. Med. CrossRef